董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Christopher Wolfe | 男 | Independent Director | 47 | 22.50万美元 | 11.58 | 2026-11-10 |
| Timothy R. Danker | 男 | Chief Executive Officer and Director | 53 | 289.99万美元 | 325.39 | 2026-11-10 |
| Donald L. Hawks III | 男 | Chairman of the Board and Independent Director | 51 | 28.56万美元 | 61.95 | 2026-11-10 |
| Earl H. Devanny III | 男 | Independent Director | 74 | 26.50万美元 | 53.30 | 2026-11-10 |
| Denise L. Devine | 女 | Independent Director | 71 | 未披露 | 未持股 | 2026-11-10 |
| Raymond F. Weldon | 男 | Independent Director | 67 | 24.75万美元 | 130.38 | 2026-11-10 |
| Srdjan Vukovic | 男 | Independent Director | 44 | 22.50万美元 | 11.58 | 2026-11-10 |
| Kavita K. Patel | 女 | Independent Director | 52 | 26.63万美元 | 49.31 | 2026-11-10 |
| Denise L. Devine | 女 | Independent Director | 70 | 28.50万美元 | 49.85 | 2026-11-10 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy R. Danker | 男 | Chief Executive Officer and Director | 53 | 289.99万美元 | 325.39 | 2026-11-10 |
| Robert Grant | 男 | President | 42 | 246.09万美元 | 643.01 | 2026-11-10 |
| Ryan M. Clement | 男 | Chief Financial Officer | 45 | 216.77万美元 | 未持股 | 2026-11-10 |
| Stephanie Fisher | 女 | Chief Accounting Officer | 49 | 未披露 | 未持股 | 2026-11-10 |
| William Grant III | 男 | Chief Operating Officer | 51 | 217.67万美元 | 590.72 | 2026-11-10 |
| Sarah Anderson | 女 | Executive Vice President,Healthcare Pharmacy Services | 48 | 未披露 | 未持股 | 2026-11-10 |
| Joshua B. Matthews | 男 | President of Insurance Distribution | 42 | 未披露 | 未持股 | 2026-11-10 |
| Daniel A. Boulware | 男 | General Counsel and Secretary | 50 | 161.43万美元 | 未持股 | 2026-11-10 |
董事简历
中英对照 | 中文 | 英文- Christopher Wolfe
-
Christopher Wolfe自2025年2月起担任公司董事。沃尔夫先生是贝恩资本保险公司的董事总经理。在2024年加入贝恩之前，Wolfe先生于2018年1月至2023年6月期间担任DFB Healthcare Acquisitions Corp.（一家公开上市的特殊目的收购公司）及其某些关联公司的首席财务官。在此之前，Wolfe先生曾于2003年至2017年担任专注于金融服务行业的私募股权基金Capital Z Partners的合伙人。Wolfe先生自2024年2月起担任私营健康保险分销商Enhance Health的董事会成员。他此前曾在直接面向消费者的保险公司Permanent General Corp.和专注于医疗保险优势的保险公司环球美国 Financial Corp.的董事会任职。沃尔夫先生以优异成绩获得了哈佛学院颁发的AB。
Christopher Wolfe has served as a director of the Company since February 2025. Mr. Wolfe is a Managing Director of Bain Capital Insurance. Prior to joining Bain in 2024, Mr. Wolfe was the Chief Financial Officer of DFB Healthcare Acquisitions Corp., a publicly traded special purpose acquisition company, and certain of its affiliates from January 2018 to June 2023. Prior to that, Mr. Wolfe was a Partner at Capital Z Partners, a private equity fund focused on the financial services industry, from 2003 to 2017. Mr. Wolfe has served as a member of the Board of Directors of Enhance Health, a privately held health insurance distributor, since February 2024. He previously served on the board of Permanent General Corp., a direct to consumer insurer, and Universal American Financial Corp., a Medicare Advantage focused insurer. Mr. Wolfe received his AB, magna cum laude, from Harvard College. - Christopher Wolfe自2025年2月起担任公司董事。沃尔夫先生是贝恩资本保险公司的董事总经理。在2024年加入贝恩之前，Wolfe先生于2018年1月至2023年6月期间担任DFB Healthcare Acquisitions Corp.（一家公开上市的特殊目的收购公司）及其某些关联公司的首席财务官。在此之前，Wolfe先生曾于2003年至2017年担任专注于金融服务行业的私募股权基金Capital Z Partners的合伙人。Wolfe先生自2024年2月起担任私营健康保险分销商Enhance Health的董事会成员。他此前曾在直接面向消费者的保险公司Permanent General Corp.和专注于医疗保险优势的保险公司环球美国 Financial Corp.的董事会任职。沃尔夫先生以优异成绩获得了哈佛学院颁发的AB。
- Christopher Wolfe has served as a director of the Company since February 2025. Mr. Wolfe is a Managing Director of Bain Capital Insurance. Prior to joining Bain in 2024, Mr. Wolfe was the Chief Financial Officer of DFB Healthcare Acquisitions Corp., a publicly traded special purpose acquisition company, and certain of its affiliates from January 2018 to June 2023. Prior to that, Mr. Wolfe was a Partner at Capital Z Partners, a private equity fund focused on the financial services industry, from 2003 to 2017. Mr. Wolfe has served as a member of the Board of Directors of Enhance Health, a privately held health insurance distributor, since February 2024. He previously served on the board of Permanent General Corp., a direct to consumer insurer, and Universal American Financial Corp., a Medicare Advantage focused insurer. Mr. Wolfe received his AB, magna cum laude, from Harvard College.
- Timothy R. Danker
-
Timothy R. Danker自2017年起担任公司首席执行官和董事会成员。Danker先生于2016年至2019年担任公司生活事业部总裁，于2015年至2016年担任公司生活事业部执行副总裁，并于2012年至2015年担任公司汽车与家居事业部总裁。在加入公司之前，Danker co先生于2007年至2012年创立并担任资深医疗保险分销平台Spring Venture Group的首席执行官。Danker先生在密苏里大学获得工商管理本科学位，在堪萨斯大学获得工商管理硕士学位。
Timothy R. Danker has served as the Company's Chief Executive Officer and a member of the Board of Directors since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas. - Timothy R. Danker自2017年起担任公司首席执行官和董事会成员。Danker先生于2016年至2019年担任公司生活事业部总裁，于2015年至2016年担任公司生活事业部执行副总裁，并于2012年至2015年担任公司汽车与家居事业部总裁。在加入公司之前，Danker co先生于2007年至2012年创立并担任资深医疗保险分销平台Spring Venture Group的首席执行官。Danker先生在密苏里大学获得工商管理本科学位，在堪萨斯大学获得工商管理硕士学位。
- Timothy R. Danker has served as the Company's Chief Executive Officer and a member of the Board of Directors since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.
- Donald L. Hawks III
-
Donald L. Hawks III自2014年起担任公司董事，并于2020年2月获委任为董事会主席。自Brookside Equity Partners LLC于2012年成立以来，他一直担任总裁和董事总经理。他是多家私营公司的董事，包括Cash Management Solutions Limited。他在洛克菲勒家族基金的投资委员会任职，并且是新风基金的董事会成员。霍克斯先生在乔治敦大学获得本科学位，在宾夕法尼亚大学沃顿商学院获得工商管理硕士学位。
Donald L. Hawks III has served as a director of the Company since 2014 and was appointed to serve as the Chairman of the Board in February 2020. He has served as the President and as a Managing Director of Brookside Equity Partners LLC since its formation in 2012. He is a director of multiple private companies, including Cash Management Solutions Limited. He serves on the Investment Committee of the Rockefeller Family Fund and is a member of the Board of Directors of the Fresh Air Fund. Mr. Hawks received his undergraduate degree from Georgetown University and his Masters in Business Administration from The Wharton School at the University of Pennsylvania. - Donald L. Hawks III自2014年起担任公司董事，并于2020年2月获委任为董事会主席。自Brookside Equity Partners LLC于2012年成立以来，他一直担任总裁和董事总经理。他是多家私营公司的董事，包括Cash Management Solutions Limited。他在洛克菲勒家族基金的投资委员会任职，并且是新风基金的董事会成员。霍克斯先生在乔治敦大学获得本科学位，在宾夕法尼亚大学沃顿商学院获得工商管理硕士学位。
- Donald L. Hawks III has served as a director of the Company since 2014 and was appointed to serve as the Chairman of the Board in February 2020. He has served as the President and as a Managing Director of Brookside Equity Partners LLC since its formation in 2012. He is a director of multiple private companies, including Cash Management Solutions Limited. He serves on the Investment Committee of the Rockefeller Family Fund and is a member of the Board of Directors of the Fresh Air Fund. Mr. Hawks received his undergraduate degree from Georgetown University and his Masters in Business Administration from The Wharton School at the University of Pennsylvania.
- Earl H. Devanny III
-
Earl H. Devanny III于2020年2月获委任为公司董事。从2016年到2021年出售，Devanny先生一直担任Tract Manager的首席执行官，该公司是一家医疗战略采购和合规应用套件提供商。Devanny先生此前曾于2014年至2016年担任为企业和消费者提供语音和语言解决方案的提供商纽昂斯通讯的医疗保健业务总裁。在此之前，Devanny先生曾于2010年至2013年担任医疗信息技术提供商Trizetto Corporation的董事长兼首席执行官。在此之前，Devanny先生于1999年至2010年担任卫生信息技术解决方案、服务、设备和硬件供应商塞纳公司的总裁。2010年至2025年4月，Devanny先生担任Commerce Bank的上市银行控股公司Commerce Bancshares, Inc.（纳斯达克股票代码：CBSH）的董事。他目前担任Accesshealthcare和McNeil Trusts的董事，这两家公司都是私营公司。Devanny先生获得了南方大学（Sewanee）的本科学位。
Earl H. Devanny III was appointed to serve as a director of the Company in February 2020. Mr. Devanny served as the Chief Executive Officer of Tract Manager, a provider of healthcare strategic sourcing and compliance application suites, from 2016 until its sale in 2021. Mr. Devanny previously served as the President of the healthcare business of Nuance Communications, a provider of voice and language solutions for businesses and consumers, from 2014 to 2016. Prior to that, Mr. Devanny served as the Chairman and Chief Executive Officer of Trizetto Corporation, a healthcare information technology provider, from 2010 to 2013. Prior to that, Mr. Devanny served as the President of Cerner Corporation, a supplier of health information technology solutions, services, devices, and hardware, from 1999 to 2010. From 2010 to April 2025, Mr. Devanny served as a director of Commerce Bancshares, Inc. (NASDAQ: CBSH), the publicly traded bank holding company for Commerce Bank. He currently serves as a director of Accesshealthcare and McNeil Trusts, both private companies. Mr. Devanny received his undergraduate degree from the University of the South (Sewanee). - Earl H. Devanny III于2020年2月获委任为公司董事。从2016年到2021年出售，Devanny先生一直担任Tract Manager的首席执行官，该公司是一家医疗战略采购和合规应用套件提供商。Devanny先生此前曾于2014年至2016年担任为企业和消费者提供语音和语言解决方案的提供商纽昂斯通讯的医疗保健业务总裁。在此之前，Devanny先生曾于2010年至2013年担任医疗信息技术提供商Trizetto Corporation的董事长兼首席执行官。在此之前，Devanny先生于1999年至2010年担任卫生信息技术解决方案、服务、设备和硬件供应商塞纳公司的总裁。2010年至2025年4月，Devanny先生担任Commerce Bank的上市银行控股公司Commerce Bancshares, Inc.（纳斯达克股票代码：CBSH）的董事。他目前担任Accesshealthcare和McNeil Trusts的董事，这两家公司都是私营公司。Devanny先生获得了南方大学（Sewanee）的本科学位。
- Earl H. Devanny III was appointed to serve as a director of the Company in February 2020. Mr. Devanny served as the Chief Executive Officer of Tract Manager, a provider of healthcare strategic sourcing and compliance application suites, from 2016 until its sale in 2021. Mr. Devanny previously served as the President of the healthcare business of Nuance Communications, a provider of voice and language solutions for businesses and consumers, from 2014 to 2016. Prior to that, Mr. Devanny served as the Chairman and Chief Executive Officer of Trizetto Corporation, a healthcare information technology provider, from 2010 to 2013. Prior to that, Mr. Devanny served as the President of Cerner Corporation, a supplier of health information technology solutions, services, devices, and hardware, from 1999 to 2010. From 2010 to April 2025, Mr. Devanny served as a director of Commerce Bancshares, Inc. (NASDAQ: CBSH), the publicly traded bank holding company for Commerce Bank. He currently serves as a director of Accesshealthcare and McNeil Trusts, both private companies. Mr. Devanny received his undergraduate degree from the University of the South (Sewanee).
- Denise L. Devine
-
Denise L. Devine自2020年2月起担任公司董事，并于2020年9月被任命为薪酬委员会主席。Devine女士是FNB Holdings，LLC的创始人，该公司致力于健康和保健领域的举措，她自2014年起担任该公司的首席执行官。Devine女士还是RTM Vital Signs，LLC的联合创始人和首席财务官，RTM Vital Signs，LLC是一家处于发展阶段的医疗器械公司。Devine女士还在1994年至2014年期间创立了Nutripharm，Inc.并担任首席执行官，该公司产生了一系列成分和工艺专利，以创造创新的天然食品、饮料、药品和营养保健品。Devine女士此前曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会董事会成员。从2005年到2015年，Devine女士是维拉诺瓦大学董事会成员，并担任审计和风险委员会主席。Devine女士于2016年至2026年期间担任宾夕法尼亚州东南部Ben Franklin Technology Partners的董事会成员。自2012年起，Devine女士还担任Fulton Financial Corporation（纳斯达克股票代码：FULT）的董事，其中还担任审计委员会主席、执行委员会副主席和风险委员会成员。自2025年以来，Devine女士还担任Innovative Solutions & Services，Inc.（纳斯达克股票代码：ISSC）的董事，她还在审计委员会和薪酬委员会任职。她此前曾于2018年至2023年出售期间担任AgroFresh Solutions Solutions，Inc.（NASDAQ：AGFS）的董事、审计委员会成员以及薪酬和人才委员会主席，并于2019年至2021年出售期间担任立方公司（NYSE：CUB）的董事。Devine女士是一名注册会计师，在宾夕法尼亚大学沃顿商学院获得工商管理硕士学位，在维拉诺瓦法学院获得税务硕士学位，在维拉诺瓦大学获得会计学本科学位。
Denise L. Devine has served as a director of the Company since February 2020 and was appointed to serve as Chair of the Compensation Committee in September 2020. Ms. Devine is the founder of FNB Holdings, LLC, a company dedicated to initiatives in the health and wellness space, of which she has served as Chief Executive Officer since 2014. Ms. Devine is also the Co Founder and Chief Financial Officer of RTM Vital Signs, LLC, a development stage medical device company. Ms. Devine also founded and served as the Chief Executive Officer from 1994 to 2014 of Nutripharm, Inc., a company that has generated a portfolio of composition and process patents to create innovative natural food, beverage, pharmaceutical, and nutraceutical products. Ms. Devine previously served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs. From 2005 to 2015, Ms. Devine was a member of the Board of Trustees of Villanova University and served as the Chair of the Audit and Risk Committee. Ms. Devine served on the Board of Ben Franklin Technology Partners of Southeastern Pennsylvania from 2016 to 2026. Since 2012, Ms. Devine has also served as a director of Fulton Financial Corporation (NASDAQ: FULT), of which she is also the Chair of the Audit Committee, the Vice Chair of the Executive Committee, and a member of the Risk Committee. Since 2025, Ms. Devine has also served as a director of Innovative Solutions & Services, Inc. (NASDAQ: ISSC), where she also serves on the Audit and Compensation Committees. She previously served as a director, member of the Audit Committee, and Chair of the Compensation and Talent Committee of AgroFresh Solutions, Inc. (NASDAQ: AGFS) from 2018 until its sale in 2023, and as a director of Cubic Corporation (NYSE: CUB) from 2019 until its sale in 2021. Ms. Devine is a Certified Public Accountant and received her Masters in Business Administration from The Wharton School at the University of Pennsylvania, her Masters in Taxation from Villanova Law School, and her undergraduate degree in Accounting from Villanova University. - Denise L. Devine自2020年2月起担任公司董事，并于2020年9月被任命为薪酬委员会主席。Devine女士是FNB Holdings，LLC的创始人，该公司致力于健康和保健领域的举措，她自2014年起担任该公司的首席执行官。Devine女士还是RTM Vital Signs，LLC的联合创始人和首席财务官，RTM Vital Signs，LLC是一家处于发展阶段的医疗器械公司。Devine女士还在1994年至2014年期间创立了Nutripharm，Inc.并担任首席执行官，该公司产生了一系列成分和工艺专利，以创造创新的天然食品、饮料、药品和营养保健品。Devine女士此前曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会董事会成员。从2005年到2015年，Devine女士是维拉诺瓦大学董事会成员，并担任审计和风险委员会主席。Devine女士于2016年至2026年期间担任宾夕法尼亚州东南部Ben Franklin Technology Partners的董事会成员。自2012年起，Devine女士还担任Fulton Financial Corporation（纳斯达克股票代码：FULT）的董事，其中还担任审计委员会主席、执行委员会副主席和风险委员会成员。自2025年以来，Devine女士还担任Innovative Solutions & Services，Inc.（纳斯达克股票代码：ISSC）的董事，她还在审计委员会和薪酬委员会任职。她此前曾于2018年至2023年出售期间担任AgroFresh Solutions Solutions，Inc.（NASDAQ：AGFS）的董事、审计委员会成员以及薪酬和人才委员会主席，并于2019年至2021年出售期间担任立方公司（NYSE：CUB）的董事。Devine女士是一名注册会计师，在宾夕法尼亚大学沃顿商学院获得工商管理硕士学位，在维拉诺瓦法学院获得税务硕士学位，在维拉诺瓦大学获得会计学本科学位。
- Denise L. Devine has served as a director of the Company since February 2020 and was appointed to serve as Chair of the Compensation Committee in September 2020. Ms. Devine is the founder of FNB Holdings, LLC, a company dedicated to initiatives in the health and wellness space, of which she has served as Chief Executive Officer since 2014. Ms. Devine is also the Co Founder and Chief Financial Officer of RTM Vital Signs, LLC, a development stage medical device company. Ms. Devine also founded and served as the Chief Executive Officer from 1994 to 2014 of Nutripharm, Inc., a company that has generated a portfolio of composition and process patents to create innovative natural food, beverage, pharmaceutical, and nutraceutical products. Ms. Devine previously served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs. From 2005 to 2015, Ms. Devine was a member of the Board of Trustees of Villanova University and served as the Chair of the Audit and Risk Committee. Ms. Devine served on the Board of Ben Franklin Technology Partners of Southeastern Pennsylvania from 2016 to 2026. Since 2012, Ms. Devine has also served as a director of Fulton Financial Corporation (NASDAQ: FULT), of which she is also the Chair of the Audit Committee, the Vice Chair of the Executive Committee, and a member of the Risk Committee. Since 2025, Ms. Devine has also served as a director of Innovative Solutions & Services, Inc. (NASDAQ: ISSC), where she also serves on the Audit and Compensation Committees. She previously served as a director, member of the Audit Committee, and Chair of the Compensation and Talent Committee of AgroFresh Solutions, Inc. (NASDAQ: AGFS) from 2018 until its sale in 2023, and as a director of Cubic Corporation (NYSE: CUB) from 2019 until its sale in 2021. Ms. Devine is a Certified Public Accountant and received her Masters in Business Administration from The Wharton School at the University of Pennsylvania, her Masters in Taxation from Villanova Law School, and her undergraduate degree in Accounting from Villanova University.
- Raymond F. Weldon
-
Raymond F. Weldon自2014年起担任公司董事，自2016年起担任审计委员会主席。他是Brookside Equity Partners LLC的联合创始人，自2012年成立以来一直担任该公司的董事总经理之一。Weldon先生自1999年以来一直受雇于Hillside Capital Incorporated，这是一家私人投资公司，是Brookside Equity Partners LLC的附属公司，目前担任其董事总经理之一。Weldon先生是一名注册会计师（非在职），并且是几家私营公司的董事。Weldon先生获得了拉萨尔大学荣誉项目的本科学位和维拉诺瓦大学的税务硕士学位。
Raymond F. Weldon has served as a director of the Company since 2014 and as the Chairman of Audit Committee since 2016. He is a co founder of Brookside Equity Partners LLC and has served as one of its Managing Directors since its formation in 2012. Mr. Weldon has been employed by Hillside Capital Incorporated, a private investment company and affiliate of Brookside Equity Partners LLC, since 1999 and currently serves as one of its Managing Directors. Mr. Weldon is a Certified Public Accountant (inactive) and is a director of several private companies. Mr. Weldon received his undergraduate degree from the Honors Program of LaSalle University and his Masters in Taxation from Villanova University. - Raymond F. Weldon自2014年起担任公司董事，自2016年起担任审计委员会主席。他是Brookside Equity Partners LLC的联合创始人，自2012年成立以来一直担任该公司的董事总经理之一。Weldon先生自1999年以来一直受雇于Hillside Capital Incorporated，这是一家私人投资公司，是Brookside Equity Partners LLC的附属公司，目前担任其董事总经理之一。Weldon先生是一名注册会计师（非在职），并且是几家私营公司的董事。Weldon先生获得了拉萨尔大学荣誉项目的本科学位和维拉诺瓦大学的税务硕士学位。
- Raymond F. Weldon has served as a director of the Company since 2014 and as the Chairman of Audit Committee since 2016. He is a co founder of Brookside Equity Partners LLC and has served as one of its Managing Directors since its formation in 2012. Mr. Weldon has been employed by Hillside Capital Incorporated, a private investment company and affiliate of Brookside Equity Partners LLC, since 1999 and currently serves as one of its Managing Directors. Mr. Weldon is a Certified Public Accountant (inactive) and is a director of several private companies. Mr. Weldon received his undergraduate degree from the Honors Program of LaSalle University and his Masters in Taxation from Villanova University.
- Srdjan Vukovic
-
Srdjan Vukovic，自2025年2月起担任公司董事。武科维奇先生是私人投资公司Sava Hill的合伙人。2018年至2025年6月，他是私募股权公司Newlight Partners LP的合伙人。在此之前，武科维奇曾任职于索罗斯基金管理公司，曾任美林证券分析师。武科维奇先生目前担任私人健康保险公司Zing Health的董事会成员，并在2026年9月之前担任行为健康公司服务提供商Jade Health的董事会成员。Vukovic先生此前曾在上市的初级保健提供商Oak Street Health的董事会任职，直至该公司于2023年被CVS收购；Zenium Data Centers，直至其于2017年被上市的CyrusOne收购；Narragansett Bay Insurance Company，直至其被出售并成为上市的Heritage Insurance Holdings, Inc.的全资子公司；以及多家私营保险公司。Vukovic先生获得了纽约大学金融和精算科学学士学位。
Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and until September 2026, served on the board of Jade Health, a service provider to behavioral health companies. Mr. Vukovic previously served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrusOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University. - Srdjan Vukovic，自2025年2月起担任公司董事。武科维奇先生是私人投资公司Sava Hill的合伙人。2018年至2025年6月，他是私募股权公司Newlight Partners LP的合伙人。在此之前，武科维奇曾任职于索罗斯基金管理公司，曾任美林证券分析师。武科维奇先生目前担任私人健康保险公司Zing Health的董事会成员，并在2026年9月之前担任行为健康公司服务提供商Jade Health的董事会成员。Vukovic先生此前曾在上市的初级保健提供商Oak Street Health的董事会任职，直至该公司于2023年被CVS收购；Zenium Data Centers，直至其于2017年被上市的CyrusOne收购；Narragansett Bay Insurance Company，直至其被出售并成为上市的Heritage Insurance Holdings, Inc.的全资子公司；以及多家私营保险公司。Vukovic先生获得了纽约大学金融和精算科学学士学位。
- Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and until September 2026, served on the board of Jade Health, a service provider to behavioral health companies. Mr. Vukovic previously served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrusOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University.
- Kavita K. Patel
-
Kavita K. Patel于2020年9月获委任为公司董事。Patel博士是斯坦福大学的医学教授，也是华盛顿特区玛丽中心的初级保健执业医师。自2017年以来，Patel博士还担任New Enterprise Associates的风险合伙人。从2011 – 2021年，她在布鲁金斯学会担任医疗保健提供和转型的董事总经理。此前，帕特尔博士曾于2009年至2010年担任白宫政府间事务和公众参与办公室政策主任，2007年至2009年担任已故参议员Edward Kennedy手下负责卫生事务的副参谋长，并担任参议院卫生、教育、劳工和养老金委员会高级职员。Patel博士自2021年12月起担任Arcellx, Inc.（纳斯达克股票代码：ACLX）的董事和薪酬委员会成员，直至2026年4月将其出售给吉利德科学，Inc.。她此前还曾于2020年4月起担任Sigilon Therapeutics, Inc.（NASDAQ：SGTX）的董事和薪酬委员会成员，直至2023年8月将其出售给礼来 and Company；于2016年至2019年被葛兰素史克收购之前担任Tesaro, Inc.，Inc.（NASDAQ：TSRO）的董事和治理与提名委员会成员；于2021年11月至2023年4月担任Intelligent Medicine Acquisition Corp（NASDAQ：TERM4IQMD）的董事、薪酬委员会成员和提名与公司治理委员会主席。帕特尔博士在得克萨斯大学奥斯汀分校获得本科学位，在加州大学洛杉矶分校获得公共卫生硕士学位，在得克萨斯大学健康科学中心获得医学学位。
Kavita K. Patel was appointed to serve as a director of the Company in September 2020. Dr. Patel is a Professor of Medicine at Stanford University and a practicing primary care physician at Mary's Center in Washington, D.C. Dr. Patel has also served as a Venture Partner at New Enterprise Associates since 2017. From 2011–2021, she was a managing director of health care delivery and transformation at the Brookings Institution. Previously, Dr. Patel served as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement in the White House from 2009 to 2010, as Deputy Staff Director on Health on the late Senator Edward Kennedy's staff from 2007 to 2009, and as a member of senior staff of the Senate Health, Education, Labor and Pensions Committee. Dr. Patel served as a director and member of the Compensation Committee of Arcellx, Inc. (NASDAQ: ACLX) from December 2021 until its sale to Gilead Sciences, Inc. in April 2026. She also previously served as a director and member of the Compensation Committee of Sigilon Therapeutics, Inc. (NASDAQ: SGTX) from April 2020 until its sale to Eli Lilly and Company in August 2023; as a director and member of the Governance and Nominating Committee of Tesaro, Inc. (NASDAQ: TSRO) from 2016 until its acquisition by GlaxoSmithKline in 2019; and as a director, member of the Compensation Committee, and Chair of the Nominating and Corporate Governance Committee of Intelligent Medicine Acquisition Corp (NASDAQ: IQMD) from November 2021 to April 2023. Dr. Patel received her undergraduate degree from the University of Texas at Austin, her Master of Public Health from the University of California at Los Angeles, and her medical degree from the University of Texas Health Science Center. - Kavita K. Patel于2020年9月获委任为公司董事。Patel博士是斯坦福大学的医学教授，也是华盛顿特区玛丽中心的初级保健执业医师。自2017年以来，Patel博士还担任New Enterprise Associates的风险合伙人。从2011 – 2021年，她在布鲁金斯学会担任医疗保健提供和转型的董事总经理。此前，帕特尔博士曾于2009年至2010年担任白宫政府间事务和公众参与办公室政策主任，2007年至2009年担任已故参议员Edward Kennedy手下负责卫生事务的副参谋长，并担任参议院卫生、教育、劳工和养老金委员会高级职员。Patel博士自2021年12月起担任Arcellx, Inc.（纳斯达克股票代码：ACLX）的董事和薪酬委员会成员，直至2026年4月将其出售给吉利德科学，Inc.。她此前还曾于2020年4月起担任Sigilon Therapeutics, Inc.（NASDAQ：SGTX）的董事和薪酬委员会成员，直至2023年8月将其出售给礼来 and Company；于2016年至2019年被葛兰素史克收购之前担任Tesaro, Inc.，Inc.（NASDAQ：TSRO）的董事和治理与提名委员会成员；于2021年11月至2023年4月担任Intelligent Medicine Acquisition Corp（NASDAQ：TERM4IQMD）的董事、薪酬委员会成员和提名与公司治理委员会主席。帕特尔博士在得克萨斯大学奥斯汀分校获得本科学位，在加州大学洛杉矶分校获得公共卫生硕士学位，在得克萨斯大学健康科学中心获得医学学位。
- Kavita K. Patel was appointed to serve as a director of the Company in September 2020. Dr. Patel is a Professor of Medicine at Stanford University and a practicing primary care physician at Mary's Center in Washington, D.C. Dr. Patel has also served as a Venture Partner at New Enterprise Associates since 2017. From 2011–2021, she was a managing director of health care delivery and transformation at the Brookings Institution. Previously, Dr. Patel served as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement in the White House from 2009 to 2010, as Deputy Staff Director on Health on the late Senator Edward Kennedy's staff from 2007 to 2009, and as a member of senior staff of the Senate Health, Education, Labor and Pensions Committee. Dr. Patel served as a director and member of the Compensation Committee of Arcellx, Inc. (NASDAQ: ACLX) from December 2021 until its sale to Gilead Sciences, Inc. in April 2026. She also previously served as a director and member of the Compensation Committee of Sigilon Therapeutics, Inc. (NASDAQ: SGTX) from April 2020 until its sale to Eli Lilly and Company in August 2023; as a director and member of the Governance and Nominating Committee of Tesaro, Inc. (NASDAQ: TSRO) from 2016 until its acquisition by GlaxoSmithKline in 2019; and as a director, member of the Compensation Committee, and Chair of the Nominating and Corporate Governance Committee of Intelligent Medicine Acquisition Corp (NASDAQ: IQMD) from November 2021 to April 2023. Dr. Patel received her undergraduate degree from the University of Texas at Austin, her Master of Public Health from the University of California at Los Angeles, and her medical degree from the University of Texas Health Science Center.
- Denise L. Devine
-
Denise L. Devine，于2018年2月加入董事会。Devine女士是FNB Holdings， LLC的创始人，并自2014年起担任首席执行官，该公司致力于健康和保健领域的倡议。Devine女士也是Nutripharm， Inc.的创始人，并担任首席执行官超过十年，该公司产生了组合和工艺专利组合，以创造创新的天然食品、饮料、制药和营养保健品，促进营养和终身健康。Devine女士是一名注册会计师，此前也曾担任Energy Solutions International的首席财务官和Campbell Soup Company的财务管理职位。Devine女士曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会董事会成员。Devine女士自2012年起担任Fulton Financial Corporation纳斯达克股票代码：FULT（“Fulton”）的董事，并担任Fulton审计委员会成员，Fulton人力资源委员会主席，以及Fulton执行委员会成员。她还担任Cubic Corporation （NYSE： CUB）的董事（2019年11月以来），并在审计委员会和技术战略委员会任职。2005年至2015年，她是Villanova University的董事会成员，担任审计和风险委员会主席。2010年至2019年，她还担任Lourdes Health System的董事会成员，直到Lourdes被收购，董事会被解散。此外，她自2016年起担任AUS， Inc.（私营公司）的董事会成员，并于2016年被任命为Ben Franklin Technology Partners of Southeastern Pennsylvania的董事会成员。她持有Pennsylvania大学沃顿商学院工商管理硕士学位、Villanova法学院税务硕士学位和Villanova大学会计学学士学位。
Denise L. Devine is the Founder and Chief Executive Officer of FNB Holdings, LLC and Co founder and Chief Financial Officer of RTM Vital Signs, LLC, a medical device and digital health company. Previoly she was founder and served for more than ten years as Chief Executive Officer of Nutripharm, Inc., served as Chief Financial Officer of Energy Solutions International and in financial management positions for Campbell Soup Company. Ms. Devine is also a named inventor on more than 30 patents. Ms. Devine currently serves on the Board of Fulton Financial Corporation (NASDAQ:FULT), SelectQuote (NYSE:SLQT) and A, Inc. Ms. Devine, a certified public accountant, served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs and as Co Chair of the Board of Ben Franklin Technology Partners. Ms. Devine has received numero honors and awards, including the "Best 50 Biness Women in Pennsylvania" Governor's Award, and The Gold Medal Alumnae Award from Villanova University. She received an MBA from the Wharton School of the University of Pennsylvania where she served as an Entrepreneur in Residence, an M.S. in Taxation from Villanova Law School and a B.S. in Accounting from Villanova University. - Denise L. Devine，于2018年2月加入董事会。Devine女士是FNB Holdings， LLC的创始人，并自2014年起担任首席执行官，该公司致力于健康和保健领域的倡议。Devine女士也是Nutripharm， Inc.的创始人，并担任首席执行官超过十年，该公司产生了组合和工艺专利组合，以创造创新的天然食品、饮料、制药和营养保健品，促进营养和终身健康。Devine女士是一名注册会计师，此前也曾担任Energy Solutions International的首席财务官和Campbell Soup Company的财务管理职位。Devine女士曾担任宾夕法尼亚州会计委员会主席和美国注册会计师协会董事会成员。Devine女士自2012年起担任Fulton Financial Corporation纳斯达克股票代码：FULT（“Fulton”）的董事，并担任Fulton审计委员会成员，Fulton人力资源委员会主席，以及Fulton执行委员会成员。她还担任Cubic Corporation （NYSE： CUB）的董事（2019年11月以来），并在审计委员会和技术战略委员会任职。2005年至2015年，她是Villanova University的董事会成员，担任审计和风险委员会主席。2010年至2019年，她还担任Lourdes Health System的董事会成员，直到Lourdes被收购，董事会被解散。此外，她自2016年起担任AUS， Inc.（私营公司）的董事会成员，并于2016年被任命为Ben Franklin Technology Partners of Southeastern Pennsylvania的董事会成员。她持有Pennsylvania大学沃顿商学院工商管理硕士学位、Villanova法学院税务硕士学位和Villanova大学会计学学士学位。
- Denise L. Devine is the Founder and Chief Executive Officer of FNB Holdings, LLC and Co founder and Chief Financial Officer of RTM Vital Signs, LLC, a medical device and digital health company. Previoly she was founder and served for more than ten years as Chief Executive Officer of Nutripharm, Inc., served as Chief Financial Officer of Energy Solutions International and in financial management positions for Campbell Soup Company. Ms. Devine is also a named inventor on more than 30 patents. Ms. Devine currently serves on the Board of Fulton Financial Corporation (NASDAQ:FULT), SelectQuote (NYSE:SLQT) and A, Inc. Ms. Devine, a certified public accountant, served as Chair of the Pennsylvania State Board of Accountancy and on the Board of the American Institute of CPAs and as Co Chair of the Board of Ben Franklin Technology Partners. Ms. Devine has received numero honors and awards, including the "Best 50 Biness Women in Pennsylvania" Governor's Award, and The Gold Medal Alumnae Award from Villanova University. She received an MBA from the Wharton School of the University of Pennsylvania where she served as an Entrepreneur in Residence, an M.S. in Taxation from Villanova Law School and a B.S. in Accounting from Villanova University.
高管简历
中英对照 | 中文 | 英文- Timothy R. Danker
Timothy R. Danker自2017年起担任公司首席执行官和董事会成员。Danker先生于2016年至2019年担任公司生活事业部总裁，于2015年至2016年担任公司生活事业部执行副总裁，并于2012年至2015年担任公司汽车与家居事业部总裁。在加入公司之前，Danker co先生于2007年至2012年创立并担任资深医疗保险分销平台Spring Venture Group的首席执行官。Danker先生在密苏里大学获得工商管理本科学位，在堪萨斯大学获得工商管理硕士学位。
Timothy R. Danker has served as the Company's Chief Executive Officer and a member of the Board of Directors since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.- Timothy R. Danker自2017年起担任公司首席执行官和董事会成员。Danker先生于2016年至2019年担任公司生活事业部总裁，于2015年至2016年担任公司生活事业部执行副总裁，并于2012年至2015年担任公司汽车与家居事业部总裁。在加入公司之前，Danker co先生于2007年至2012年创立并担任资深医疗保险分销平台Spring Venture Group的首席执行官。Danker先生在密苏里大学获得工商管理本科学位，在堪萨斯大学获得工商管理硕士学位。
- Timothy R. Danker has served as the Company's Chief Executive Officer and a member of the Board of Directors since 2017. Mr. Danker served as the President of the Company's Life Division from 2016 to 2019, as the Executive Vice President of the Company's Life Division from 2015 to 2016, and as the President of the Company's Auto & Home Division from 2012 to 2015. Prior to joining the Company, Mr. Danker co founded and served as the Chief Executive Officer of Spring Venture Group, a senior healthcare insurance distribution platform, from 2007 to 2012. Mr. Danker received his undergraduate degree in business administration from the University of Missouri and his Master of Business Administration from the University of Kansas.
- Robert Grant
Robert Grant自2021年10月起担任公司总裁。Grant先生此前曾于2019年至2021年担任公司高级部门总裁；2017年至2019年担任公司首席营收官；2016年至2017年担任公司人寿部门销售高级副总裁；2013年至2016年担任公司高级部门销售和运营总监。格兰特先生获得了堪萨斯大学的本科学位。
Robert Grant has served as the President of the Company since October 2021. Mr. Grant previously served as the President of the Company's Senior Division from 2019 to 2021; the Company's Chief Revenue Officer from 2017 to 2019; the Senior Vice President of Sales of the Company's Life Division from 2016 to 2017; and as the Director of Sales and Operations for the Company's Senior Division from 2013 to 2016. Mr. Grant received his undergraduate degree from the University of Kansas.- Robert Grant自2021年10月起担任公司总裁。Grant先生此前曾于2019年至2021年担任公司高级部门总裁；2017年至2019年担任公司首席营收官；2016年至2017年担任公司人寿部门销售高级副总裁；2013年至2016年担任公司高级部门销售和运营总监。格兰特先生获得了堪萨斯大学的本科学位。
- Robert Grant has served as the President of the Company since October 2021. Mr. Grant previously served as the President of the Company's Senior Division from 2019 to 2021; the Company's Chief Revenue Officer from 2017 to 2019; the Senior Vice President of Sales of the Company's Life Division from 2016 to 2017; and as the Director of Sales and Operations for the Company's Senior Division from 2013 to 2016. Mr. Grant received his undergraduate degree from the University of Kansas.
- Ryan M. Clement
Ryan M. Clement自2023年2月起担任公司首席财务官。Clement先生于2022年1月加入公司，担任财务规划与分析高级副总裁，并于2022年6月被任命为临时首席财务官。在加入公司之前，Clement先生于2019年至2022年担任Sifted，LLC（前身为VeriShip）（一家基于SaaS的私营软件技术公司）的首席财务官。2012年至2016年，Clement先生在Mutual Fund Store担任财务副总裁，负责财务规划和分析，并在并购中发挥核心作用。继2016年将Mutual Fund Store出售给公开交易的独立注册投资顾问Financial Engines, Inc.后，Clement先生曾担任Financial Engines分销战略副总裁，后来在2018年实体合并后担任该公司与爱德曼金融服务公司的整合主管，负责监督该公司的整合工作。Clement先生拥有密苏里大学房地产和金融与银行业MBA和双学士学位。
Ryan M. Clement has served as the Company's Chief Financial Officer since February 2023. Mr. Clement joined the Company in January 2022 as the Senior Vice President of Financial Planning & Analysis and was appointed Interim Chief Financial Officer in June 2022. Before joining the Company, Mr. Clement was the Chief Financial Officer of Sifted, LLC (formerly VeriShip), a private SaaS based software technology firm, from 2019 to 2022. From 2012 to 2016, Mr. Clement was Vice President of Finance at The Mutual Fund Store, where he was responsible for financial planning and analysis and played a central role in M&A. Following the sale of The Mutual Fund Store in 2016 to Financial Engines, Inc., a publicly traded independent registered investment adviser, Mr. Clement served as Vice President of Distribution Strategy at Financial Engines and later oversaw its integration with Edelman Financial Services as Head of Integration following the entities' merger in 2018. Mr. Clement holds an MBA and a dual B.S. in Real Estate and Finance & Banking from the University of Missouri.- Ryan M. Clement自2023年2月起担任公司首席财务官。Clement先生于2022年1月加入公司，担任财务规划与分析高级副总裁，并于2022年6月被任命为临时首席财务官。在加入公司之前，Clement先生于2019年至2022年担任Sifted，LLC（前身为VeriShip）（一家基于SaaS的私营软件技术公司）的首席财务官。2012年至2016年，Clement先生在Mutual Fund Store担任财务副总裁，负责财务规划和分析，并在并购中发挥核心作用。继2016年将Mutual Fund Store出售给公开交易的独立注册投资顾问Financial Engines, Inc.后，Clement先生曾担任Financial Engines分销战略副总裁，后来在2018年实体合并后担任该公司与爱德曼金融服务公司的整合主管，负责监督该公司的整合工作。Clement先生拥有密苏里大学房地产和金融与银行业MBA和双学士学位。
- Ryan M. Clement has served as the Company's Chief Financial Officer since February 2023. Mr. Clement joined the Company in January 2022 as the Senior Vice President of Financial Planning & Analysis and was appointed Interim Chief Financial Officer in June 2022. Before joining the Company, Mr. Clement was the Chief Financial Officer of Sifted, LLC (formerly VeriShip), a private SaaS based software technology firm, from 2019 to 2022. From 2012 to 2016, Mr. Clement was Vice President of Finance at The Mutual Fund Store, where he was responsible for financial planning and analysis and played a central role in M&A. Following the sale of The Mutual Fund Store in 2016 to Financial Engines, Inc., a publicly traded independent registered investment adviser, Mr. Clement served as Vice President of Distribution Strategy at Financial Engines and later oversaw its integration with Edelman Financial Services as Head of Integration following the entities' merger in 2018. Mr. Clement holds an MBA and a dual B.S. in Real Estate and Finance & Banking from the University of Missouri.
- Stephanie Fisher
Stephanie Fisher自2020年8月起担任公司首席会计官。在加入公司之前，Fisher女士是YRC Worldwide，Inc.（纳斯达克股票代码：YELL）（现为Yellow Corporation）的首席财务官，这是一家北美零担运输公司，在那里她领导了公司财务和运营职能的战略转型。在2017年被任命为首席财务官之前，Fisher女士曾在YRC的多个高级会计职位任职十多年，包括副总裁兼财务总监和财务报告总监。Fisher女士在堪萨斯州立大学获得工商管理学士学位和会计学硕士学位后，开始了她在安永会计师事务所的鉴证业务的职业生涯。
Stephanie Fisher has served as the Company's Chief Accounting Officer since August 2020. Prior to joining the Company, Ms. Fisher was the Chief Financial Officer of YRC Worldwide, Inc. (NASDAQ: YELL) (now Yellow Corporation), a North American less than truckload transportation company, where she led a strategic transformation of the company's finance and operations functions. Before her appointment as Chief Financial Officer in 2017, Ms. Fisher spent over a decade in various senior level accounting positions at YRC, including Vice President & Controller and Director of Financial Reporting. Ms. Fisher began her career in the Assurance practice of Ernst & Young LLP after earning her B.S. in Business Administration and Master of Accountancy from Kansas State University.- Stephanie Fisher自2020年8月起担任公司首席会计官。在加入公司之前，Fisher女士是YRC Worldwide，Inc.（纳斯达克股票代码：YELL）（现为Yellow Corporation）的首席财务官，这是一家北美零担运输公司，在那里她领导了公司财务和运营职能的战略转型。在2017年被任命为首席财务官之前，Fisher女士曾在YRC的多个高级会计职位任职十多年，包括副总裁兼财务总监和财务报告总监。Fisher女士在堪萨斯州立大学获得工商管理学士学位和会计学硕士学位后，开始了她在安永会计师事务所的鉴证业务的职业生涯。
- Stephanie Fisher has served as the Company's Chief Accounting Officer since August 2020. Prior to joining the Company, Ms. Fisher was the Chief Financial Officer of YRC Worldwide, Inc. (NASDAQ: YELL) (now Yellow Corporation), a North American less than truckload transportation company, where she led a strategic transformation of the company's finance and operations functions. Before her appointment as Chief Financial Officer in 2017, Ms. Fisher spent over a decade in various senior level accounting positions at YRC, including Vice President & Controller and Director of Financial Reporting. Ms. Fisher began her career in the Assurance practice of Ernst & Young LLP after earning her B.S. in Business Administration and Master of Accountancy from Kansas State University.
- William Grant III
William Grant III自2019年起担任公司首席运营官。Grant先生此前曾于2017年至2019年担任公司首席营销官和公司高级部门总裁，并于2012年至2017年担任公司高级部门营销高级副总裁。格兰特先生获得了堪萨斯大学的本科学位。
William Grant III has served as the Company's Chief Operating Officer since 2019. Mr. Grant previously served as the Company's Chief Marketing Officer and President of the Company's Senior Division from 2017 to 2019 and as the Senior Vice President of Marketing for the Company's Senior Division from 2012 to 2017. Mr. Grant received his undergraduate degree from the University of Kansas.- William Grant III自2019年起担任公司首席运营官。Grant先生此前曾于2017年至2019年担任公司首席营销官和公司高级部门总裁，并于2012年至2017年担任公司高级部门营销高级副总裁。格兰特先生获得了堪萨斯大学的本科学位。
- William Grant III has served as the Company's Chief Operating Officer since 2019. Mr. Grant previously served as the Company's Chief Marketing Officer and President of the Company's Senior Division from 2017 to 2019 and as the Senior Vice President of Marketing for the Company's Senior Division from 2012 to 2017. Mr. Grant received his undergraduate degree from the University of Kansas.
- Sarah Anderson
Sarah Anderson自2024年7月起担任医疗保健药房服务执行副总裁。安德森女士于2018年加入公司，担任高级部门营销高级总监，曾担任多个高级营销和运营职位，包括营销运营高级副总裁和医疗保健执行副总裁。从2002 – 2018年，安德森女士曾任职于斯普林特公司（现为T Mobile US），担任财务、营销和运营等多个职务。安德森女士在圣安东尼奥三一大学就读后，在德克萨斯州休斯顿的安然公司开始了她的职业生涯。
Sarah Anderson has served as the Executive Vice President of Healthcare Pharmacy Services since July 2024. Ms. Anderson joined the Company in 2018 as the Senior Director of Marketing for the Senior division and has held a variety of senior marketing and operations positions, including Senior Vice President of Marketing Operations and Executive Vice President of Healthcare. From 2002–2018, Ms. Anderson worked for Sprint Corporation (now T Mobile US) in multiple roles across finance, marketing, and operations. Ms. Anderson began her professional career at Enron Corporation in Houston, Texas after attending Trinity University in San Antonio.- Sarah Anderson自2024年7月起担任医疗保健药房服务执行副总裁。安德森女士于2018年加入公司，担任高级部门营销高级总监，曾担任多个高级营销和运营职位，包括营销运营高级副总裁和医疗保健执行副总裁。从2002 – 2018年，安德森女士曾任职于斯普林特公司（现为T Mobile US），担任财务、营销和运营等多个职务。安德森女士在圣安东尼奥三一大学就读后，在德克萨斯州休斯顿的安然公司开始了她的职业生涯。
- Sarah Anderson has served as the Executive Vice President of Healthcare Pharmacy Services since July 2024. Ms. Anderson joined the Company in 2018 as the Senior Director of Marketing for the Senior division and has held a variety of senior marketing and operations positions, including Senior Vice President of Marketing Operations and Executive Vice President of Healthcare. From 2002–2018, Ms. Anderson worked for Sprint Corporation (now T Mobile US) in multiple roles across finance, marketing, and operations. Ms. Anderson began her professional career at Enron Corporation in Houston, Texas after attending Trinity University in San Antonio.
- Joshua B. Matthews
Joshua B. Matthews自2026年8月起担任保险分销总裁。Matthews先生于2014年首次加入公司，曾在高级部门担任多个行政职务，包括总裁、医疗保险销售运营执行副总裁和销售高级副总裁。Matthews先生在堪萨斯州立大学获得工商管理本科学位，在罗克赫斯特大学获得数学硕士学位。
Joshua B. Matthews has served as the President of Insurance Distribution since August 2026. Mr. Matthews first joined the Company in 2014 and has served in several executive positions within the Senior division, including President, Executive Vice President of Medicare Sales Operations, and Senior Vice President of Sales. Mr. Matthews received his undergraduate degree in Business Administration from Kansas State University and his Masters in Mathematics from Rockhurst University.- Joshua B. Matthews自2026年8月起担任保险分销总裁。Matthews先生于2014年首次加入公司，曾在高级部门担任多个行政职务，包括总裁、医疗保险销售运营执行副总裁和销售高级副总裁。Matthews先生在堪萨斯州立大学获得工商管理本科学位，在罗克赫斯特大学获得数学硕士学位。
- Joshua B. Matthews has served as the President of Insurance Distribution since August 2026. Mr. Matthews first joined the Company in 2014 and has served in several executive positions within the Senior division, including President, Executive Vice President of Medicare Sales Operations, and Senior Vice President of Sales. Mr. Matthews received his undergraduate degree in Business Administration from Kansas State University and his Masters in Mathematics from Rockhurst University.
- Daniel A. Boulware
Daniel A. Boulware自2019年10月起担任公司总法律顾问和秘书。在加入公司之前，Boulware先生是SS & C Health的副总裁兼总法律顾问，该公司是SS&C科技控股公司的医疗保健部门，该公司是一家向金融服务行业提供技术以及向医疗保健行业提供药房福利管理、医疗索赔处理、数据分析和其他技术的上市公司。Boulware先生的职业生涯始于2002年，当时他是Polsinelli PC的一名合伙人，并于2012年成为该公司的股东。Boulware先生获得了堪萨斯大学的本科学位、法学博士和工商管理硕士学位。
Daniel A. Boulware has served as the Company's General Counsel and Secretary since October 2019. Prior to joining the Company, Mr. Boulware was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc., a public company providing technology to the financial services industry and pharmacy benefit management, medical claims processing, data analytics, and other technology to the healthcare industry. Mr. Boulware began his career in 2002 as an Associate at Polsinelli PC, where he was made Shareholder in 2012. Mr. Boulware earned his undergraduate degree, Juris Doctor and Master of Business Administration from the University of Kansas.- Daniel A. Boulware自2019年10月起担任公司总法律顾问和秘书。在加入公司之前，Boulware先生是SS & C Health的副总裁兼总法律顾问，该公司是SS&C科技控股公司的医疗保健部门，该公司是一家向金融服务行业提供技术以及向医疗保健行业提供药房福利管理、医疗索赔处理、数据分析和其他技术的上市公司。Boulware先生的职业生涯始于2002年，当时他是Polsinelli PC的一名合伙人，并于2012年成为该公司的股东。Boulware先生获得了堪萨斯大学的本科学位、法学博士和工商管理硕士学位。
- Daniel A. Boulware has served as the Company's General Counsel and Secretary since October 2019. Prior to joining the Company, Mr. Boulware was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc., a public company providing technology to the financial services industry and pharmacy benefit management, medical claims processing, data analytics, and other technology to the healthcare industry. Mr. Boulware began his career in 2002 as an Associate at Polsinelli PC, where he was made Shareholder in 2012. Mr. Boulware earned his undergraduate degree, Juris Doctor and Master of Business Administration from the University of Kansas.